Gian Life Care Peer Comparison

BSE: 542918

₹4.54

₹0.01 (0.22%)

As on 16-Oct-2026IST

Market cap

₹5 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Market cap (₹ Cr)	5	33,362	31,206	28,796	18,133
Revenue (₹ Cr)	4	4,683	2,891	4,213	1,446
Net Profit (₹ Cr)	-0.95	552.34	546.30	190.80	164.14
Net Margin (%)	-24.68	11.55	18.23	4.49	11.28
RoE (%)	-5.01	14.93	23.03	9.45	15.36
Price to Earnings	--	59.98	57.59	140.95	108.85
Price-To-Book	0.25	8.11	11.94	7.61	12.75

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Operating Revenue	6.63	3,692.35	2,461.40	3,035.10	1,020.42
Total Income	6.90	3,797.15	2,554.83	3,067.00	1,027.94
Total Expenditure	5.68	2,831.90	1,765.80	2,242.10	758.20
EBITDA	0.95	860.44	695.60	793.00	262.22
Depreciation	0.63	193.75	141.92	177.20	44.55
EBIT	0.32	666.69	553.67	615.80	217.67
Interest	0.55	74.35	22.31	100.40	17.66
Other Income	0.26	104.81	93.43	31.90	7.52
Exceptional Items	--	-49.90	--	10.80	-11.13
Profit before Tax	0.04	647.26	624.80	558.10	194.43
Provision for Tax	0.08	165.94	132.55	143.30	55.85
Profit after Tax	-0.04	481.32	492.25	414.80	138.58

Liabilities (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Shareholder's Funds	19.23	3,386.41	2,172.72	2,137.80	968.39
Minority Interest	0.00	1.10	33.76	281.00	-1.11
Non-Current Liabilities	4.10	726.88	21.34	2,421.10	5.66
Current Liabilities	12.60	618.82	402.35	836.20	441.67
Total Liabilities	35.93	4,766.23	2,713.41	5,689.20	1,461.26

Assets (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Non-Current Assets	17.60	3,200.08	1,266.66	4,978.80	484.78
Current Assets	18.33	1,533.12	1,363.51	697.30	929.83
Total Assets	35.93	4,766.23	2,713.41	5,689.20	1,461.26
Total Debt*	5.84	327.88	0.00	1,910.90	123.16
Net Current Assets	5.73	914.31	961.16	-138.90	488.17
Contingent Liabilities	--	88.77	10.59	83.80	110.61

Cashflow (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Cash From Operating Activities	0.27	623.76	568.89	581.80	287.10
Cash Flow from Investing Activities	0.25	-720.94	-303.16	-1,116.20	-122.65
Cash from Financing Activities	0.45	-97.23	-334.03	543.10	-26.15
Net Cash Inflow / Outflow	0.97	-194.41	-68.31	8.70	138.30

Ratios

Profitability Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
ROCE (%)	2.39	20.50	31.53	19.02	20.30
ROE (%)	-0.19	15.31	25.15	20.92	15.47
ROA (%)	-0.11	10.72	19.53	8.74	10.63
EBIT Margin (%)	18.36	26.14	32.06	27.18	26.43
Net Margin (%)	-0.54	12.68	19.27	13.52	13.48
Cash Profit Margin (%)	8.92	18.28	25.76	19.51	17.95

Growth Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Revenue Growth (%)	-49.46	12.74	10.54	21.49	21.98
EBIT Growth (%)	-82.14	9.24	16.31	24.83	13.20
Net Profit Growth (%)	-100.90	0.68	35.87	23.49	65.88
EPS Growth (%)	-100.90	0.65	35.99	24.03	42.20
Book Value Growth (%)	-0.23	16.71	17.68	16.93	17.66

Valuation Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Price / Earnings	0.00	66.85	21.26	66.51	0.00
Price / Book Value	0.92	9.50	9.79	11.96	0.00
Dividend Yield (%)	0.00	0.04	0.97	0.00	--
EV/EBITDA	13.68	32.52	25.19	33.22	-0.01
Market Cap (₹ Cr)	17.77	32,181.74	20,714.85	25,571.93	0.00

Solvency Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Debt to Equity	0.30	0.10	0.00	0.89	0.13
Short term debt to equity ratio	0.12	--	--	0.06	0.11
Current Ratio	1.45	2.48	3.39	0.83	2.11
Quick Ratio	1.40	2.37	3.30	0.76	1.12
Interest Coverage	1.07	9.71	29.01	6.56	12.01

Operating Efficiency Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Molbio Diagnostics
Debtors to sales (%)	91.80	7.90	3.58	13.03	26.62
Asset Turnover	0.19	0.82	0.98	0.64	0.78
Receivable days	299.97	25.07	12.27	41.48	124.68
Inventory Days	41.38	6.62	5.45	6.82	134.33
Payable days	1,058.24	79.17	134.04	135.60	142.62
Cash Conversion Cycle	-716.89	-47.48	-116.32	-87.31	116.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.